Quick answers
- What is Wegovy?
- Wegovy is a brand name of Semaglutide, a prescription medicine. The FDA NDC Directory lists 12 Wegovy products in 11 strengths and forms.
- Who makes Wegovy?
- Novo holds the FDA application for Wegovy (NDA215256, approved June 4, 2021). 1 other company (repackagers or distributors) also list Wegovy products.
- Is there a generic or store brand of Wegovy?
- Yes. The FDA NDC Directory lists 3 other products with the same active ingredients, strength and form as a Wegovy product. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Wegovy?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 10 Wegovy strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Wegovy been recalled?
- FDA enforcement reports list 3 recalls of Wegovy products; the newest started December 19, 2025. A recall usually concerns specific lots, not every product.
What Wegovy is
Each Wegovy product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Semaglutide · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| semaglutide 0.25 mg/0.5 mL injection, solution (subcutaneous) | Wegovy | None listed | DailyMed |
| semaglutide 0.5 mg/0.5 mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 1 mg/0.5 mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 1.5 mg tablet (oral) | Wegovy | 1 product, 1 company | — |
| semaglutide 1.7 mg/0.75 mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 2.4 mg/0.75 mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 25 mg tablet (oral) | Wegovy | None listed | — |
| semaglutide 3.2 mg/mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 4 mg tablet (oral) | Wegovy | 1 product, 1 company | — |
| semaglutide 7.2 mg/0.75 mL injection, solution (subcutaneous) | Wegovy | None listed | — |
| semaglutide 9 mg tablet (oral) | Wegovy | 1 product, 1 company | — |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Semaglutide →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| semaglutide 0.25 mg/0.5 mL injection, solution | Brand: Wegovy | $653.33 per mL |
| semaglutide 0.5 mg/0.5 mL injection, solution | Brand: Wegovy | $653.30 per mL |
| semaglutide 1 mg/0.5 mL injection, solution | Brand: Wegovy | $653.07 per mL |
| semaglutide 1.5 mg tablet | Brand: Wegovy | $43.53 per tablet |
| semaglutide 1.7 mg/0.75 mL injection, solution | Brand: Wegovy | $435.57 per mL |
| semaglutide 2.4 mg/0.75 mL injection, solution | Brand: Wegovy | $435.57 per mL |
| semaglutide 25 mg tablet | Brand: Wegovy | $43.46 per tablet |
| semaglutide 4 mg tablet | Brand: Wegovy | $43.49 per tablet |
| semaglutide 7.2 mg/0.75 mL injection, solution | Brand: Wegovy | $434.94 per mL |
| semaglutide 9 mg tablet | Brand: Wegovy | $43.48 per tablet |
NADAC list of November 4, 2026; these prices took effect on October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Wegovy
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Wegovy products.
- Novo Nordisk Pharmaceutical Industries, LP11 products
- A-S Medication Solutions1 product
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 19, 2025 · Class II · Ongoing · D-0245-2026
Presence of Particulate Matter: Hair was found in a prefilled syringe
Wegovy (semaglutide) Injection, 1 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, NDC — Novo Nordisk Inc.
-
December 19, 2025 · Class II · Ongoing · D-0244-2026
Presence of Particulate Matter: Hair was found in a prefilled syringe
Wegovy (semaglutide) Injection, 0.5 mg/0.5 mL, 4 Single-Dose Prefilled Pens, Manufactured by: Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark, Product of Denmark, Novo Nordisk A/S, Novo Nordisk Inc., Plainsboro, NJ 08536, N — Novo Nordisk Inc.
-
April 9, 2025 · Class II · Ongoing · D-0393-2025
Temperature abuse: Wegovy product was potentially exposed to temperatures outside of the products labeled storage conditions due to a shipping error involving a Cardinal Health distribution center. More specifically, product was removed from refrigerated storage for an extended period of time and inappropriately releas
Wegovy (semaglutide) injection, 2.4 mg/0.75 mL, 4 Single-Dose Prefilled Pens per Carton, For Subcutaneous Use Only, Rx Only, Single-Dose Only, Novo Nordisk Inc., Plainsboro, NJ 08536, Manufactured by: Novo Nordisk A/S, D — Cardinal Health Inc.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.